Intensive blood glucose control is safe and effective in diabetic cats using home monitoring and treatment with glargine (Q34991769)

5 August 2017

Intensive blood glucose control is safe and effective in diabetic cats using home monitoring and treatment with glargine (English)

1 reference

5 August 2017

1 reference

Kirsten Roomp

1

1 reference

PubMed ID

19592286

5 August 2017

Jacquie Rand

series ordinal

2

1 reference

5 August 2017

9 July 2009

1 reference

Journal of Feline Medicine and Surgery

5 August 2017

1 reference

5 August 2017

11

1 reference

5 August 2017

8

1 reference

5 August 2017

668-682

1 reference

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

5 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2009.04.010

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2009.04.010

Considerations for diabetes translational research in real-world settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2009.04.010

Current understanding of feline diabetes: part 2, treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2009.04.010

Glargine and protamine zinc insulin have a longer duration of action and result in lower mean daily glucose concentrations than lente insulin in healthy cats

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2009.04.010

Pharmacology of a 40 IU/ml porcine lente insulin preparation in diabetic cats: findings during the first week and after 5 or 9 weeks of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2009.04.010

The usage of a simplified self-titration dosing guideline (303 Algorithm) for insulin detemir in patients with type 2 diabetes--results of the randomized, controlled PREDICTIVE 303 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2009.04.010

Initiation of insulin glargine therapy in type 2 diabetes subjects suboptimally controlled on oral antidiabetic agents: results from the AT.LANTUS trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2009.04.010

Improving glycemic control with insulin detemir using the 303 Algorithm in insulin naïve patients with type 2 diabetes: a subgroup analysis of the US PREDICTIVE 303 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2009.04.010

Diabetes mellitus in cats

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2009.04.010

Comparison of a low carbohydrate-low fiber diet and a moderate carbohydrate-high fiber diet in the management of feline diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2009.04.010

Insulin sensitivity, fat distribution, and adipocytokine response to different diets in lean and obese cats before and after weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2009.04.010

The carnivore connection to nutrition in cats

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2009.04.010

Involvement of oxidative stress in the pathogenesis of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2009.04.010

Hyperglycaemia but not hyperlipidaemia causes beta cell dysfunction and beta cell loss in the domestic cat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2009.04.010

Diabetes mellitus and periodontal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2009.04.010

Home-monitoring of blood glucose in cats with diabetes mellitus: evaluation over a 4-month period

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2009.04.010

Home monitoring of the diabetic cat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2009.04.010

A comparison of bedtime insulin glargine with bedtime neutral protamine hagedorn insulin in patients with type 2 diabetes: subgroup analysis of patients taking once-daily insulin in a multicenter, randomized, parallel group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2009.04.010

Glargine is superior to neutral protamine Hagedorn for improving glycated haemoglobin and fasting blood glucose levels during intensive insulin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2009.04.010

Approved IFCC recommendation on reporting results for blood glucose (abbreviated).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2009.04.010

Measurement of circulating glucose concentrations: the time is now for consistency among methods and types of samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2009.04.010

The distribution of sodium, potassium and glucose in the blood of some mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JFMS.2009.04.010

10.1016/J.JFMS.2009.04.010

21 January 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference

PubMed ID

19592286